During the past decade, Massachusetts General Hospital Cancer Center conducted 274 clinical trials. In the 10-year time frame, 274 clinical trials started and 161 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 131 clinical trials started and 79 clinical trials were completed. i.e. 60.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Massachusetts General Hospital Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 175 trials, followed by "Massachusetts General Hospital" with 70 trials sponsored, "Children's Oncology Group" with 67 trials sponsored, "Alliance for Clinical Trials in Oncology" with 35 trials sponsored and "Radiation Therapy Oncology Group" with 35 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 214 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Genentech, Inc." with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Cancer and Leukemia Group B" with 9 trials as a collaborator. Other collaborators include 202 different institutions and companies that were collaborators in the rest 124 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Cancer Center" are "Breast Cancer" (31 trials), "Brain and Central Nervous System Tumors" (24 trials), "Lymphoma" (22 trials), "Leukemia" (19 trials) and "Lung Cancer" (19 trials). Many other conditions were trialed in "Massachusetts General Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital Cancer Center" are "Drug" (431 trials), "Other" (205 trials), "Biological" (149 trials), "Radiation" (129 trials) and "Procedure" (117 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (124 trials), "Quality-of-Life Assessment" (49 trials), "Cyclophosphamide" (40 trials), "Radiation Therapy" (36 trials) and "Carboplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital Cancer Center" are 479 trials for "All" genders, 66 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital Cancer Center". 7 are not yet recruiting, 115 are recruiting, 152 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 228 completed trials in Massachusetts General Hospital Cancer Center, 7 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital Cancer Center, 131 "Phase 1" clinical trials were conducted, 265 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 38 trials that are defined as “Not Applicable".